BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22531722)

  • 21. Neurotropin suppresses itch-related behavior in NC/Nga mice with atopic dermatitis-like symptoms.
    Kamo A; Tominaga M; Matsuda H; Kina K; Kamata Y; Umehara Y; Ogawa H; Takamori K
    J Dermatol Sci; 2016 Mar; 81(3):212-5. PubMed ID: 26725918
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
    Andoh T; Yoshida T; Kuraishi Y
    Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis.
    Hashimoto Y; Arai I; Takano N; Tanaka M; Nakaike S
    Br J Dermatol; 2006 Jan; 154(1):28-33. PubMed ID: 16403090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
    Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
    Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice.
    Takano N; Arai I; Kurachi M
    Br J Dermatol; 2006 Mar; 154(3):426-30. PubMed ID: 16445770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary deficiencies of unsaturated fatty acids and starch cause atopic dermatitis-like pruritus in hairless mice.
    Fujii M; Shimazaki Y; Muto Y; Kohno S; Ohya S; Nabe T
    Exp Dermatol; 2015 Feb; 24(2):108-13. PubMed ID: 25387853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain mechanism of itch in atopic dermatitis and its possible alteration through non-invasive treatments.
    Mochizuki H; Schut C; Nattkemper LA; Yosipovitch G
    Allergol Int; 2017 Jan; 66(1):14-21. PubMed ID: 27688121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of bepotastine besilate suppressed scratching behavior of atopic dermatitis model NC/Nga mice.
    Tanizaki H; Kambe N; Nakamura Y; Tanaka A; Matsuda H; Miyachi Y
    Int Arch Allergy Immunol; 2008; 145(4):277-82. PubMed ID: 18004068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
    Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
    Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis.
    Back SK; Jeong KY; Li C; Lee J; Lee SB; Na HS
    J Dermatol Sci; 2012 Aug; 67(2):111-9. PubMed ID: 22721998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
    Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
    J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Itch and atopic dermatitis: an overview.
    Wahlgren CF
    J Dermatol; 1999 Nov; 26(11):770-9. PubMed ID: 10635621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions.
    Andoh T; Haza S; Saito A; Kuraishi Y
    Exp Dermatol; 2011 Nov; 20(11):894-8. PubMed ID: 21824199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of treatment on itch in atopic dermatitis.
    Yarbrough KB; Neuhaus KJ; Simpson EL
    Dermatol Ther; 2013; 26(2):110-9. PubMed ID: 23551368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim CH; Cheong KA; Park CD; Lee AY
    Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and therapy of pruritus in allergic and atopic diseases.
    Buddenkotte J; Steinhoff M
    Allergy; 2010 Jul; 65(7):805-21. PubMed ID: 20384615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of the chronic itch of atopic dermatitis using standard drugs and kampo medicines.
    Yamashita H; Tanaka H; Inagaki N
    Biol Pharm Bull; 2013; 36(8):1253-7. PubMed ID: 23902969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocytes in the spinal dorsal horn and chronic itch.
    Tsuda M
    Neurosci Res; 2018 Jan; 126():9-14. PubMed ID: 28870604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis.
    Imada T; Komorita N; Kobayashi F; Naito K; Yoshikawa T; Miyazaki M; Nakamura N; Kondo T
    Jpn J Pharmacol; 2002 Nov; 90(3):214-7. PubMed ID: 12499574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic pruritus--pathogenesis, clinical aspects and treatment.
    Metz M; Ständer S
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1249-60. PubMed ID: 20846147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.